Cyanata Therapeutics

Follow
Follow Organisations, People and Lists Upgrade your subscription to use this feature.
Cynata Therapeutics Limited (ASX: CYP) is a Melbourne-based stem cell and regenerative medicine company that is developing a
therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader
in stem cell research. The proprietary Cymerus™ technology addresses a critical shortcoming in existing methods of
production of mesenchymal stem cells (MSCs) for therapeutic use, which is the ability to achieve economic manufacture at
commercial scale.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options